Havenga M - Search Results

1

Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus.

Veltrop-Duits LA, Heemskerk B, Sombroek CC, van Vreeswijk T, Gubbels S, Toes RE, Melief CJ, Franken KL, Havenga M, van Tol MJ, Schilham MW. Veltrop-Duits LA, et al. Among authors: havenga m. Eur J Immunol. 2006 Sep;36(9):2410-23. doi: 10.1002/eji.200535786. Eur J Immunol. 2006. PMID: 16933360 Free article.

2

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

Rea D, Havenga MJ, van Den Assem M, Sutmuller RP, Lemckert A, Hoeben RC, Bout A, Melief CJ, Offringa R. Rea D, et al. Among authors: havenga mj. J Immunol. 2001 Apr 15;166(8):5236-44. doi: 10.4049/jimmunol.166.8.5236. J Immunol. 2001. PMID: 11290808

3

Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset.

Rea D, Schagen FH, Hoeben RC, Mehtali M, Havenga MJ, Toes RE, Melief CJ, Offringa R. Rea D, et al. Among authors: havenga mj. J Virol. 1999 Dec;73(12):10245-53. doi: 10.1128/JVI.73.12.10245-10253.1999. J Virol. 1999. PMID: 10559341 Free PMC article.

4

Strategies for improved antigen delivery into dendritic cells.

Rea D, Johnson ME, Havenga MJ, Melief CJ, Offringa R. Rea D, et al. Among authors: havenga mj. Trends Mol Med. 2001 Mar;7(3):91-4. doi: 10.1016/s1471-4914(01)01948-7. Trends Mol Med. 2001. PMID: 11286763

5

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.

Slager EH, Borghi M, van der Minne CE, Aarnoudse CA, Havenga MJ, Schrier PI, Osanto S, Griffioen M. Slager EH, et al. Among authors: havenga mj. J Immunol. 2003 Feb 1;170(3):1490-7. doi: 10.4049/jimmunol.170.3.1490. J Immunol. 2003. PMID: 12538712

6

Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.

Persson BD, John L, Rafie K, Strebl M, Frängsmyr L, Ballmann MZ, Mindler K, Havenga M, Lemckert A, Stehle T, Carlson LA, Arnberg N. Persson BD, et al. Among authors: havenga m. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2020732118. doi: 10.1073/pnas.2020732118. Proc Natl Acad Sci U S A. 2021. PMID: 33384338 Free PMC article.

7

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

Havenga MJ, Lemckert AA, Ophorst OJ, van Meijer M, Germeraad WT, Grimbergen J, van Den Doel MA, Vogels R, van Deutekom J, Janson AA, de Bruijn JD, Uytdehaag F, Quax PH, Logtenberg T, Mehtali M, Bout A. Havenga MJ, et al. J Virol. 2002 May;76(9):4612-20. doi: 10.1128/jvi.76.9.4612-4620.2002. J Virol. 2002. PMID: 11932426 Free PMC article.

8

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.

Lemckert AAC, Grimbergen J, Smits S, Hartkoorn E, Holterman L, Berkhout B, Barouch DH, Vogels R, Quax P, Goudsmit J, Havenga MJE. Lemckert AAC, et al. J Gen Virol. 2006 Oct;87(Pt 10):2891-2899. doi: 10.1099/vir.0.82079-0. J Gen Virol. 2006. PMID: 16963747

9

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Holterman L, Vogels R, van der Vlugt R, Sieuwerts M, Grimbergen J, Kaspers J, Geelen E, van der Helm E, Lemckert A, Gillissen G, Verhaagh S, Custers J, Zuijdgeest D, Berkhout B, Bakker M, Quax P, Goudsmit J, Havenga M. Holterman L, et al. Among authors: havenga m. J Virol. 2004 Dec;78(23):13207-15. doi: 10.1128/JVI.78.23.13207-13215.2004. J Virol. 2004. PMID: 15542673 Free PMC article.

10

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.

Sumida SM, Truitt DM, Lemckert AA, Vogels R, Custers JH, Addo MM, Lockman S, Peter T, Peyerl FW, Kishko MG, Jackson SS, Gorgone DA, Lifton MA, Essex M, Walker BD, Goudsmit J, Havenga MJ, Barouch DH. Sumida SM, et al. Among authors: havenga mj. J Immunol. 2005 Jun 1;174(11):7179-85. doi: 10.4049/jimmunol.174.11.7179. J Immunol. 2005. PMID: 15905562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page